Fig. 1From: Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5LMean FACT-8D and EQ-5D-5L (Crosswalk and England value set) Index scores and standard errors by study visit for patients completing the assessment at week 31 (n = 130)Back to article page